<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="215">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04376879</url>
  </required_header>
  <id_info>
    <org_study_id>2020-A01076-33</org_study_id>
    <nct_id>NCT04376879</nct_id>
  </id_info>
  <brief_title>Predicting the Need for Intubation in Hospitalised COVID-19 Patients (PRED ICU COVID19)</brief_title>
  <official_title>Predicting the Need for Intubation in Hospitalised COVID-19 Patients (PRED ICU COVID19)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Central Hospital, Nancy, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Central Hospital, Nancy, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      One of the main challenges of the health crisis caused by the COVID-19 epidemic is the&#xD;
      availability of beds in intensive care units (ICUs) and, more importantly, the need for&#xD;
      invasive mechanical ventilation (IVM) because the ICUs are currently reserved for intubated&#xD;
      patients.&#xD;
&#xD;
      The experiences of both China and Italy indicate that a certain number of COVID-19 patients&#xD;
      will require mechanical ventilation. However, the limited number of resuscitation beds and&#xD;
      ventilators requires strict use of these scarce resources. As a significant proportion about&#xD;
      5% to 10%, of patients initially admitted to hospital with COVID-19 will require ventilation,&#xD;
      it is essential to anticipate their need for resuscitation to improve the rare resource of&#xD;
      beds and ventilator shortages in intensive care units.&#xD;
&#xD;
      The hypothesis of the study is that, in proven or suspected hospitalised and oxygen-requiring&#xD;
      COVID-19 patients, an early predictive clinical score, calculated over the three first days&#xD;
      of admission may allow for an earlier identification of patients who will require intubation&#xD;
      and transfer to an intensive care unit for orotracheal intubation&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 16, 2020</start_date>
  <completion_date type="Anticipated">May 2022</completion_date>
  <primary_completion_date type="Anticipated">May 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>the number of intubations in COVID-19 patients initially hospitalised in wards</measure>
    <time_frame>up to 1 month</time_frame>
    <description>Primary outcome measure for the creation of the predictive score</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>the number of intubations in COVID-19 patients initially hospitalised in wards.</measure>
    <time_frame>up to 1 month</time_frame>
    <description>Secondary endpoints for validation of the predictive score</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">384</enrollment>
  <condition>COVID-19</condition>
  <arm_group>
    <arm_group_label>Step 1: creation of the score</arm_group_label>
    <description>Cohort for the creation of clinical-biological score to predict the risk of intubation in COVID-19</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Step 2: validation of the score</arm_group_label>
    <description>Cohort for the validation of clinical-biological score to predict the risk of intubation in COVID-19</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Data monitoring for 48h within the first 24 hours of admission for COVID-19</intervention_name>
    <description>The admission variables and those constituting the predictive score (blood pressure, temperature, oxygenotherapy, biological analysis...) will be collected for 48 hours after enrolment (i.e within the first 24 hours of admission )</description>
    <arm_group_label>Step 1: creation of the score</arm_group_label>
    <arm_group_label>Step 2: validation of the score</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Proven or expected COVID-19 patients hospitalised in a non-intensive care unit for less&#xD;
        than 24 hours&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Proven or expected COVID-19 patients hospitalised in a non-intensive care unit for&#xD;
             less than 24 hours,&#xD;
&#xD;
          -  Patients requiring oxygen therapy,&#xD;
&#xD;
          -  Age ≥ 18 years old.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients who are opposed to taking part in the study and who are opposed to the&#xD;
             collection and use of the data that the study aims to collect.,&#xD;
&#xD;
          -  Patients who can not be intubated for medical reasons,&#xD;
&#xD;
          -  Pregnant women, parturient women or nursing mothers ,&#xD;
&#xD;
          -  Adult person subject to a legal protection measure (guardianship, curatorship,&#xD;
             judicial safeguard),&#xD;
&#xD;
          -  Adults person who is unable to give consent and who is not subject to a legal&#xD;
             protection measure,&#xD;
&#xD;
          -  Persons deprived of their liberty by a judicial or administrative decision,&#xD;
&#xD;
          -  Persons subject to psychiatric care under duress.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Antoine KIMMOUN, MD-PhD</last_name>
    <role>Study Chair</role>
    <affiliation>CHRU de NANCY</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jean Damien RICARD, MD-PhD</last_name>
    <role>Study Chair</role>
    <affiliation>AP-HP, Louis Mourier Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Julie JOSSE, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Institut National de Recherche en Informatique et en Automatique</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Patrick ROSSIGNOL, MD-PhD</last_name>
    <role>Study Chair</role>
    <affiliation>CHRU de NANCY</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Antoine KIMMOUN, MD-PhD</last_name>
    <phone>+33 3 83 15 40 79</phone>
    <email>a.kimmoun@chru-nancy.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Patrick ROSSIGNOL, MD-PhD</last_name>
    <phone>+33 3 83 15 73 22</phone>
    <email>p.rossignol@chru-nancy.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Louis Mourier hospital (AP-HP)</name>
      <address>
        <city>Colombes</city>
        <zip>92700</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean Damien RICARD, MD-PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Brabois Hospital (CHRU de Nancy)</name>
      <address>
        <city>Vandœuvre-lès-Nancy</city>
        <zip>54500</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antoine KIMMOUN, MD-PhD</last_name>
      <email>a.kimmoun@chru-nancy.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>May 4, 2020</study_first_submitted>
  <study_first_submitted_qc>May 5, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 6, 2020</study_first_posted>
  <last_update_submitted>January 15, 2021</last_update_submitted>
  <last_update_submitted_qc>January 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

